Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

960 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New cardiovascular biomarkers in patients with advanced cancer - A prospective study comparing MR-proADM, MR-proANP, copeptin, high-sensitivity troponin T and NT-proBNP.
Anker MS, Lück LC, Khan MS, Porthun J, Hadzibegovic S, Lena A, Wilkenshoff U, Weinländer P, Evertz R, Totzeck M, Mahabadi AA, Rassaf T, Anker SD, Bullinger L, Keller U, Karakas M, Landmesser U, Butler J, von Haehling S. Anker MS, et al. Among authors: keller u. Eur J Heart Fail. 2024 Nov 26. doi: 10.1002/ejhf.3497. Online ahead of print. Eur J Heart Fail. 2024. PMID: 39600145
Safety and Efficacy of Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma in a Multinational Real-World Study.
Shumilov E, Wurm-Kuczera R, Kerkhoff A, Wang M, Melchardt T, Holtick U, Bacher U, Staber PB, Mazzeo P, Leng C, Böckle D, Hölscher AS, Kauer J, Rotter N, Vucinic V, Rudzki JD, Nachbaur D, Bücklein VL, Schnetzke U, Krämer I, Wille K, Hasse A, von Tresckow B, Hänel M, Koenecke C, Velazquez GF, Viardot A, Schmid C, Thurner L, Wolf D, Subklewe M, Dreyling M, Dreger P, Dietrich S, Keller U, Jaeger U, Greil R, Pabst T, Lenz G, Chapuy B. Shumilov E, et al. Among authors: keller u. Blood Adv. 2024 Dec 11:bloodadvances.2024014903. doi: 10.1182/bloodadvances.2024014903. Online ahead of print. Blood Adv. 2024. PMID: 39661985
Therapy-related AML: long-term outcome in a large cohort of AML-patients with intensive and non-intensive therapy.
Gross S, Ihlow J, Busack L, Adamiak K, Schrezenmeier J, Jesse J, Schwarz M, Flörcken A, Vuong LG, Rieger K, Krönke J, le Coutre P, Boldt V, von Brünneck AC, Horst D, Burmeister T, Blau IW, Keller U, Bullinger L, Westermann J. Gross S, et al. Among authors: keller u. Blood Cancer J. 2024 Sep 16;14(1):160. doi: 10.1038/s41408-024-01140-5. Blood Cancer J. 2024. PMID: 39284846 Free PMC article.
A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patients with advanced multiple myeloma.
Krüger J, Obenaus M, Blau IW, Hoser D, Vaegler M, Rauschenbach H, Anagnostopoulos I, Jöhrens K, Scheuplein V, Kieback E, Böhme J, Von Brünneck AC, Krönke J, Busse A, Willimsky G, Blankenstein T, Pezzutto A, Keller U, Nogai A. Krüger J, et al. Among authors: keller u. Haematologica. 2024 Sep 12. doi: 10.3324/haematol.2024.286124. Online ahead of print. Haematologica. 2024. PMID: 39279443 Free article.
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma).
Tournilhac O, Altmann B, Friedrichs B, Bouabdallah K, Leclerc M, Cartron G, Turlure P, Reimer P, Wagner-Drouet E, Sanhes L, Houot R, Roussel M, Kroschinsky F, Dreger P, Viardot A, de Leval L, Rosenwald A, Gaulard P, Wulf G, Villate A, Latiere C, Elmaagacli A, Glass B, Poeschel V, Damaj G, Sibon D, Durot E, Bilger K, Banos A, Haenel M, Dreyling M, Keller U, Tiab M, Drenou B, Cornillon J, Nguyen S, Robin M, Nickelsen M, Trümper L, Lenz G, Ziepert M, Schmitz N; French Lymphoma Study Association (LYSA), the Société Francophone de greffe de moelle et Thérapie Cellulaire (SFGM-TC), and the German Lymphoma Alliance (GLA). Tournilhac O, et al. Among authors: keller u. J Clin Oncol. 2024 Nov 10;42(32):3788-3794. doi: 10.1200/JCO.24.00554. Epub 2024 Sep 13. J Clin Oncol. 2024. PMID: 39270145 Clinical Trial.
V-ToCs (Venom Toxin Clustering): A tool for the investigation of sequence and structure similarities in snake venom toxins.
Kalogeropoulos K, Rosca V, O'Brien C, Christensen CR, Grahadi R, Sørensen CV, Overath MD, Espi DR, Jenkins DE, Keller UAD, Laustsen AH, Fryer TJ, Jenkins TP. Kalogeropoulos K, et al. Among authors: keller uad. Toxicon. 2024 Nov 6;250:108088. doi: 10.1016/j.toxicon.2024.108088. Epub 2024 Aug 31. Toxicon. 2024. PMID: 39222754 Free article.
960 results